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Fragile X syndrome (FXS) is the most common cause of inherited mental 
retardation caused by expansion of a (CGG) repeat region up to 1000 repeat 
in 5’ region of the FMR1 gene located in FRAXA locus Xq27.3. To better 
understand the mechanism involved in expansion of CGG region, the 
molecular characteristic of the flanking microsatellite markers in the region 
must be clarify in different populations. We aimed to examine the potential 
association between specific haplotype and the expanded AC-repeat region in 
cases and controls chromosomes. 
Materials & Methods 
Forty unrelated FXS males and 62 unrelated normal males originating from 
various regions of Iran were haplotyped by analyzing two CA-repeat markers, 
FRAXAC1 and DXS548. 
Results 
Significant linkage disequilibrium was obtained between DXS548 and 
FRAXAC1 specific marker alleles and CGG repeat expansion among 40 
fragile X cases compared to 62 normal controls. The frequencies of DXS548 
and FRAXAC1 longer alleles in patients were significantly higher than that 
in control group. Two FRAXAC1 long alleles were only observed in cases, 
possibly due to concatenated mutations. The increase of heterozygosities 
in fragile X cases (DXS548 78.6%, FRAXAC1 64.6%) in comparison to 
the controls (DXS548 63.0%, FRAXAC1 47.0%) showed a multimodal 
distribution of fragile X associated alleles. 
Conclusion
Haplotype analyses with DXS548 and FRAXAC1 markers represented 
that haplotype distribution in the normal controls and FXS patients were 
significantly different, representing a weak founder effect.
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Introduction
Fragile X syndrome (FXS) is the most common cause of inherited mental 
retardation observed approximately 1 in 4000 males and 1 in 8000 females (1, 2). 
Males with FXS usually have mental retardation and often exhibit characteristic 
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than common classic Mendelian traits. While passage 
through a female meiosis is necessary for significant 
trinucleotide repeat expansion, the most likely 
expansion occurs during early embryonic development. 
Since expansion occurs in a multicellular embryo and 
the extent of expansion may vary from cell to cell, 
individuals often display somatic heterogeneity in allele 
size. Some affected individuals, termed mosaics, exhibit 
both a premutation and a full mutation in blood. 
A full mutation contained more than 200 CGG repeats 
is commonly associated with gene promoter methylation 
and is related to gene inactivation. Gene inactivation is 
main cause of FX phenotype. However, its impact on 
severity of its clinical presentation is somehow uncertain 
mainly in females (7). 
Two microsatellite AC-repeat markers, DXS548 and 
FRAXAC1, have demonstrated significant linkage 
disequilibrium at the FMR1 locus in populations from 
various geographic areas. They located 150 kb and 7 kb 
centromeric proximal to CGG repeats, respectively, and 
known the most widely used markers for truncated STR-
based haplotyping in investigations on FMR1 and its 
correlations with FXS (8). The utility of microsatellite 
markers for association studies has reduced with the 
developments of direct testing it has been recommended 
for laboratories to have access to this marker for 
occasional unusual or complicated cases especially when 
mother of cases is carrier for CGG repeat expansion and 
already had an affected son. Using these markers the 
segregation of affected chromosome can be follow up in 
suspected cases even in a multiplex PCR. 
This is the first study has aimed to detect the correlation 
between CGG repeat haplotype of the two polymorphic 
markers DXS548 and FRAXAC1 and Iranian FXS 
compared to the distribution of those haplotypes in 
normal Iranian population in who living in and around 
Tehran. The expansion of FRAXA related microsatellites 
could help application of these molecular markers in 
diagnosis of FXS as well as better understanding of 
genomic instability in the FRAXA locus in FXS.
Materials & Methods  
Subjects selected for DXS548-FRAXAC1 haplotype 
analysis included 40 unrelated fragile-X male patients and 
62 unrelated normal males. DNA of patients was donated 
physical features such as macroorchidism and distinct 
facial features including long face, large ears, and 
prominent jaw. Affected females exhibit a similar 
but usually less severe phenotype. It is caused by the 
unstable expansion of a CGG repeat within the FMR1 
gene and abnormal methylation that induced decreased 
level of FMR1 mRNA and its FRMP level in the brain 
(3). The diagnosis of FXS was originally based on the 
expression of a folate-sensitive fragile site at Xq27.3 
(FRAXA) induced in cell culture under conditions of 
folate deprivation in cytogeneic test. Interpretation for 
fragile site on X chromosome in cytogenetic test has low 
resolution and complicating by the presence three other 
fragile sites, 1 proximal and 2 distal to FRAXA, termed 
FRAXD, FRAXE and FRAXF respectively (4, 5). 
FMR1 gene is located in FRAXA locus contained a 
tandemly repeated trinucleotide sequence (CGG) near 
its 5’ end. The mutation responsible for FXS involves 
the expansion of this repeat segment. The number of 
CGG repeats in the FMR1 gene of the normal population 
varies from 6 to approximately 50. There are two main 
categories of mutations, premutations of approximately 
60 to 250 repeats and full mutations of more than 
approximately 250 repeats. There is no clear boundary 
between the upper limit of normal and the lower limit 
of the premutation range. For this reason alleles with 
approximately 45-55 copies of the repeat are said to be 
in the “gray zone”. Some alleles in this size range are 
unstable and expand from generation to generation, while 
others are stably inherited. A premutation is susceptible 
to expansion after passage through a female meiosis. 
The larger size of a mother’s premutation the more the 
risk of expansion to a full mutation in her offspring (6).
Transporter of a premutation is not FX. Male transporters 
are nominated as “normal transmitting” males and they 
transfer the mutation to their daughters without a length 
change. These daughters are unaffected, but are at risk 
of having affected offspring. Variable clinical severity 
is observed in both sexes. Most, but not all, males with 
a full mutation are mentally retarded and show typical 
physical and behavioral features. Of females with a 
full mutation, approximately one-third is of normal 
intelligence, one-third is of borderline intelligence, and 
one-third is mentally retarded. 
Inheritance of FX mutations, are more complicated 
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Taq DNA polymerase (Roche, Germany). PCR thermal 
cycle was performed in 32 cycles. Each cycle consisted 
of 95 °C denaturizing for 30 seconds, 60 °C annealing 
for 1 minute and 72 °C extension for 40 seconds. The 
thermal cycles were started with an initial denaturizing 
of 95 °C for 5 min and a final of 72 °C extension for 10 
min.
Evaluation of polymorphism was carried out using 
denaturing polyacrylamide gel electrophoresis contained 
8% polyacrylamide (29:1 acrylamide/bisacrylamide), 
7M urea, 1XTBE, 500 ml 10% ammonium persulfate, 
and 50 ml TEMED. Gels were leaved to polymerize 
at room temperature for 1 hour. The gel apparatus was 
DNA sequencing unit (30 X 45 cm) connected to 2000V 
power supply clamps. PCR products (25 ml) were mixed 
with 45 ml of loading buffer and denatured at 95 °C for 
8 min. Denatured samples were cooled on ice and 8ml of 
each sample was loaded. Gels were run at 50 °C constant 
temperature and 100 watts limiting power for about 3 
hours (BioRad Power/Pak 3000 power supply). Gels 
were stained and alleles were visualized using standard 
silver staining procedure. 
Statistical Analysis
DXS548 and FRAXAC1 alleles were named by base pair 
marking (12). For representation of haplotypes, DXS548 
alleles have been introduced as reported earlier (11, 13) 
and for FRAXAC1 alleles were introduced (14, 15).
Expected marker heterozygosity was calculated using 
the formula 1 - q2 where q  is the frequency of each 
individual allele at FRAXAC1 and DXS548 locus. The 
Chi- square test was employed to test significance of 
differences between allele frequencies and haplotypes 
in fragile X patients and controls, SPSS 12.0 software 
(Chicago, IL, USA).
Results
CGG Repeat Analysis 
General distribution of the CGG repeat within 62 
unaffected Iranian population resulted in variable alleles, 
ranging in size 11-38 repeats, were detected as alleles 
26 (13.0%), 29 (24.0%), and 33 (11.0%) being the most 
common (Table 1).
Allele Polymorphism at DXS548 and FRAXAC1
The distribution of DXS548 and FRAXAC1 alleles in 
by Dr H. Najmabadi, University of Social Welfare and 
Rehabilitation Sciences, Tehran, Iran, Tehran, Iran. All 
patients had been identified to have fragile site at Xq27.3 
(FRAXA) using PCR and Southern blot analysis. 
Controls were 62 age/sex matched unrelated healthy 
subjects from the same geographic area. Genomic DNA 
was extracted from peripheral blood leukocytes using a 
commercial kit (QIAamp DNA Mini Kit). 
Informed consent was obtained from all participants and 
the study was approved by the Ethics Committee of the 
center. 
CGG Repeat Analysis 
To describe the general distribution of the CGG repeat 
structures within an unaffected Iranian population, 
the numbers of FMR1 CGG repeats were determined 
initially in 62 chromosomes of Iranians living in Tehran 
City that were from different cities of Iran related 
to various indigenous communities. PCR analysis 
for detection of CGG repeat in the FMR1 gene was 
performed by PCR-PAGE method using forward 
5’agccccgcacttccaccaccagctcctcca3’ and reverse 
5’cgacctgtcaccgcccttcagccttcc3’ primers (9). PCR 
conditions was started by an initial denaturation at 95 
˚C for 5 minute, followed by 10 cycles of 95 ˚C for 1 
min, 65 ˚C for 1.5 min, and 72 ˚C for 1.5 min and 30 
cycles with 55 ˚C for 1.0 min annealing temperature. 
Each 20 µl reaction contained 2.0 µl Taq buffer, 0.5 
µM each primers, 200 µM each dNTPs except for 50 
µM dGtp and 150 µM 7deza dGtp, 5% DMSO and 
1unite Pfu polymerase. The products were resolved on 
8% denaturing polyacrylamide gels and visualized by 
silver staining. A control sample of about 50 repeats was 
always considered for comparison.
DXS548-FRAXAC1 Haplotype 
The DXS548 AC-repeat polymorphism was amplified 
using forward 5’gtacattagagtcacctgtggtgc3’ and 
reverse 5’agagcttcactatgcaatggaatc3’ primers in 
amplification conditions described by Riggins et al 
(10). FRAXAC1 polymorphism was amplified using 
forward 5’gatctaatcaacatctatagactttatt3’ and reveres 
5’gatgagagtcacttgaagctgg3’ primers (11). PCR 
amplification was carried out in separate assays in a 
total volume of 25ml contained 50ng genomic DNA, 
200 mM dNTPs, 20 Pmol of each primer, 2.5 ml of 10X 
Taq DNA polymerase buffer, 1.5mM MgCl2, and 0.5U 
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subjects of normal controls and FXS is listed in Table 
2. The DXS548 alleles were 9 (190), 8 (192), 7 (194), 
6 (196), 5 (198), 4 (200), 3(202), and 2 (204) and the 
FRAXAC1 alleles were E (104), D (106), C (108), B 
(110), and A (112) respectively.
In the 62 normal X chromosomes, we observed 6 alleles 
in DXS548 locus (2, 3, 4, 5, 6, 7, 8 and 9 corresponding 
to PCR products of 202, 200, 198, 196, 194, 192 and 
190bp, respectively) that the most frequent DXS548 
allele was allele 7 (58%), followed by allele 6 (14.9%) 
(Table 2). In FXS group 5, however, alleles 2, 3 ,4 , 6, 
and 7 were observed that alleles 3 and 6 were the most 
common alleles (25%). 
As shown in Table 2 up to five FRAXAC1 alleles 
including alleles E, D, C, B and A were observed in 
Table 1. Distribution of (CGG)n Alleles in 62 normal 
X Chromosomes of Iranian





























Total heterozygosity 62 1.0
N=number of X chromosomes;  f=frequency.
Table 2. Allele Frequency of DXS548 and FRAXAC1
bp(ACs)/Allele Control (%) FXS(%)
DXS548
190 (18)/9  1(1.6) 0
192 (19)/8 3(4.8) 0
194 (20)/7 36(58) 9(22.5)
196 (21)/6 9(14.6) 10(25)
198 (22)/5 2(3.22) 0(0)
200 (23)/4 6(4.67) 6(15)
202 (24)/3 3(4.83) 10(25)
204 (25)/2  2(3.22) 5(12/5)
206 (26)/1 0 0
Total 62 40
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the fragile X chromosomes and three alleles C , D and 
E in control group with a predominance in the allele 
C among both groups (%55 in FXS group and 48.3% 
in control group). The allele distributions at DXS548 
locus and FRAXC1 in the controls and FXS groups 
were significantly different, as P=0.001 and P=0.00, 
respectively. Heterozygosity of DXS548 was 37.06% 
in controls and increased to 78.68% in the FXS group. 
Observed heterozygosities for FRAXAC1 were 53.07% 
and 35.37% in control and FXS groups, respectively.
Haplotype Analysis
Distribution of haplotypes in 62 normal individuals with 
different CGG repeats is shown in Table 3. The CGG 
repeats >29 was recognized in 22 normal individuals and 
was related with haplotypes 7D {31, 33, 36, 35 repeats}, 
7C {32, 33}, 6C {31}, 4C {30, 31, 33}, 6D {34}, 3C 
{35, 37}, 5D {36}, 8C {38}, and 9D {35}. Haplotypes 
5D, 7E, 2C, 8D, and 4D were only observed in lower 
number of CGG repeats of normal individuals with <28 
repeats.
Figure 1 shows DXS548-FRAXAC1 haplotype 
frequency distribution in control (n=62) and FXS (n=40) 
subjects. Haplotypes 7D (29%) and 6C (17.5%) were 
presented in higher incidence among control and FXS 
groups, respectively. The distribution of DXS548 allele 
size in our Iranian subjects with fragile X syndrome has 
been compared with published data in other countries in 
Table 4. 
Discussion 
We detected 21 different normal alleles ranging in size 
  Table 3. Haplotype distribution of DXS548-FRAXAC1 among 62 normal individuals
Haplotype N (%)  n(CGG repeats)
7D(194-106) 18(29) 1(12), 1(14), 1(19), 4(26), 1(27), 1(28), 1(29), 1(31), 3(33), 2(35), 2(36)  
7C(194-108) 15(24.2) 3(21), 1(25), 7(29), 2(32), 2(33)
6C(196-108) 5(8.06) 2(26), 2(29), 1(31)
4C(200-108) 4(6.45) 1(23), 1(30), 1(31), 1(33)
6D(196-106) 4(6.45) 1(28), 2(29),1(34)
3C(202-108) 3(4.83) 1(23),1(35), 1(37)
5D(198-106) 3(4.83) 2(29), 1(36)
7E(194-104) 3(4.83) 1(11), 1(22), 1(29)
2C(204-108) 2(3.25) 1(26), 1(29)







 n=number of patients
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Fig.1. DXS548–FRAXAC1 haplotype frequency distribution in unrelated non-fragile X control chromosomes (n=62) and fragile 
X chromosomes (n=40) from the Iranian population. Label of each bar indicates the haplotype percentage.
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Table 4. DXS548 allele size distribution in subjects with fragile X syndromes in Iran compared published data   
DXS548
206 204 202 200 198 196 194 192 190
other Total Reference
1 2 3 4 5 6 7 8 9
Iran 0 5 10 6 0 10 9 0 0 0 40  Present study
USA 2 21 11 6 1 26 49 9 0 0 125 Oberle 1991
France & 
Spain
1 29 1 1 0 32 42 0 0 0 106 Smits  1993
Belgium-
Holand
0 25 0 1 0 14 27 1 0 0 68 Richards 1992
N Eroup& 
USA
3 13 3 2 1 6 22 0 0 0 50 Zhong 1994
Italy 7 36 12 2 0 24 36 7 0 1 120 Oudet 1993
UK 1 8 0 0 0 16 15 4 0 0 44 Buyle 1993
Sweden 0 2 0 0 0 12 14 0 0 0 28 Riggings 1992
Finland 0 5 0 0 0 0 54 1 0 0 60 Chiurazzi 1994
Finland 0 2 0 0 0 0 35 0 0 0 37
Macpherson 
1994
Finland 0 2 0 0 0 0 24 0 0 0 26 Malmgren 1994
Portugal 0 15 0 0 8 9 9 0 0 1 42 Peixoto 1998
Spain 0 10 0 0 1 3 5 0 0 0 19 Yolando 2002
Indian 0 1 0 0 0 0 6 9 5 0 21
Chakraborty 
2008
Taiwan 0 0 0 0 0 0 27 1 0 0 28 Tzeng 2005
Central main-
land of China
0 0 0 0 0 20 6 1 0 0 27
Zhong 1994 
&1999
from 11 to 38 CGG repeats as alleles 26 (13.0%), 29 
(24.0%) and 33 (11.0%) being the most common. The 
most common fragile X CGG repeat was 29 copies in 
our study. These data are in agreement with findings 
previously reported in Asian population (16) such as 
Indian (17) and Andalusia (18).
The increase of heterozygosities has been observed in 
FXS samples for DXS548 (78.63%) locus relative to 
the controls (37.07%). The increase of heterozygosity 
in FXS patients have been observed in nearly every 
population studied (12, 19-21) and this indicants 
multimodal distribution of the fragile X linked alleles 
and the presence of one dominant allele in the controls. 
The most frequent allele in our control group was allele 
7 (194 bp) observed in 58% of individuals. A unimodal 
distribution with a high frequency of 80–90% of the 
194 allele is also recognized in many populations like 
the Caucasians, Chinese, Japanese, and the Thais. In 
control group, the modal allele 194 was flanked by 196 
at a frequency of 14.6%. However, the 194 and 192 
alleles were present in approximately equal frequencies 
43% and 41%, respectively, in two different ethically 
population of eastern and north India (22,23) while 
the frequency of 192 allele (4.8%) was not as high 
as frequency of allele 194 in the present study. We 
detected the 204 allele at a lower frequency (3.22%) in 
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agreement with the common origin of the Indo-European 
populations. Table 4 summarized the frequencies of 
alleles of DXS548 locus in FXS subjects in the major 
populations of the world and the studied population. 
Comparison of the frequency of alleles between FXS 
and control subjects reveals a significant P value <0.001 
and chi square 23.66 representing association between 
longer allele in DXS548 and FXS due to either founder 
effect or concatenated mutation. The heterozygosity of 
our normal group (37.06%) is higher than the Chinese 
(33%) and Thai (16.5%) population which indicate the 
heterogeneity of the studied Iranian population by us.
Moreover the number of longer alleles was higher 
in FXS samples than that of controls for both tested 
microsatellite markers. The percentage of longer alleles 
2 and 3 for DXS548 in cases group was 12.5% and 
25% in comparison to 3.2% and 4.8% in control group 
respectively. The percentage of longer alleles A and B 
for FRAXAC1 in FXS group was 10% and 12.5% in 
comparison to 0.0% in control group. In addition, some 
short alleles such as 8 and 9 for DXS548 were only 
observed in control group equal to 6.5%. FRAXAC1 
alleles distribution showed five different kinds of allele 
in our cases (A, B, C, D, and E) and three (C, D, and E) 
in normal population. The alleles A (21 repeat) and B (20 
repeat) were absent in our normal population whereas they 
were participated in 22.5% of haplotypes in FXS group. 
Therefore A and B alleles were associated with fragile 
X chromosomes in our population. The FRAXAC1 
locus alleles C (48.3%) and D (45.1%) were modal with 
a higher frequency in controls, whereas in FXS locus 
allele C (55%) was modal with a higher frequency in 
case group. The D and C alleles are the most frequent 
in Asian and Caucasians populations, respectively (24). 
Heterozygosity of 53% was comparable to the British 
(50%) and Chinese (49%).
The DXS548-2 (204bp) allele is known to be common 
on FMR1 founder chromosomes in Europeans (14, 16, 
25), but this allele is not observed in Asian fragile X 
chromosomes (19, 26), while, we observed this allele 
in FXS group with 12/5%. The individuals included in 
our study are from Tehran which is a metropolitan city 
where people from different area of Iran are living. The 
genetic status of these individuals is thus a complex from 
different region of Iran and it is not surprising that the 
allele frequencies observed in the 2 polymorphic loci 
DXS548 and FRAXAC1 were as a model for Iranian 
population. The results of the CA repeat analysis at 
DXS548-FRAXAC1 in the normal X chromosomes 
and Fragile X chromosomes was 13 and 18 different 
haplotypes, respectively. There was two single major 
haplotype within each group as has been found in 
different ethnic groups of the world (13-15, 19, 23, 25, 
28-30) where founder effects have been demonstrated. 
Of the 18 haplotypes represented in the FXS group, 
ten haplotypes were not observed in the control group. 
This suggests the likely of the admixture of immigrant 
haplotypes in our population, which is highly probable.
The most significant haplotype was 7D represented in 
29.0% of the X chromosomes followed by 7C (24.2%) 
and 6C (8.06%). The modal haplotype 7D, instead 
of the nearly worldwide haplotype 7C, had been also 
observed exclusively in Eastern Asian populations (8). 
Therefore, this haplotype can be considered a hallmark 
feature distinguishing the Iranian population from the 
extensive predominance of haplotype 7C observed in 
normal X chromosomes from most other populations. 
The modal haplotype 7D in our population was similar 
with previous report in normal Mexican Mestizo and 
Indigenous populations (8).
The haplotype 8D, that was not observed in our 
population, has been exclusively reported almost in 
East Asian populations (Chinese and Taiwanese) with a 
significantly lower frequency (1-4%) and the Mexican 
population (23.8%). Moreover, haplotype 6D detected in 
5.3% of the Mexican population is found in most other 
populations at a comparable frequency (1-13%; except 
25% in Eskimos). The second modal haplotype 8D was 
observed in 23.8% of the Mexican population has been 
reported almost exclusively in East Asian populations 
(Chinese and Taiwanese) but at a significantly lower 
frequency (1-4%). Moreover, haplotype 6D detected 
in 6.45% of the studied population is reported in most 
other populations at a comparable frequency (1-13%; 
except 25% in Eskimos). The haplotype 6C which is 
8.3% among normal populations was found to be the 
most frequent haplotype with frequency of 17.5% in 
our fragile X population that followed by 3C, 4C and 
7C (10%) each. The 6D haplotype has been found to 
be the most common haplotype among the fragile X 
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chromosome in white Americans, Chinese, and British 
population. However, it has not been found among the 
fragile X chromosomes in ours and the Indian, Thai 
population (23). It occurs in our FXS group at 5% 
frequency. In addition, 7D is known the most frequent 
haplotype in Thai population in both controls and cases 
but 7D was not observed in our population.
Of the 23 haplotypes in FXS group, 10 were not present 
in the control group. Therefore, these haplotypes were 
found to be associated with expansion of CGG repeats in 
our population. This suggests the likely of the admixture 
of immigrant haplotypes in Iranian population which 
is highly probable. Despite the lack of single modal 
haplotype in this highly heterogeneous population, 
haplotype distribution between the controls and FXS 
groups is significantly different (P<0.01). This suggests 
weak founder effect.
In conclusion, the CA repeat analysis at DXS548-
FRAXAC1 loci in the normal X chromosomes and 
Fragile X chromosomes represented 13 and 18 different 
haplotypes, respectively. A few unique longer alleles A 
and B for FRAXAC1 was found in FXS chromosomes 
compared to normal controls which represent a weak 
founder effect.
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